Today on TheBrief
Fast, reliable briefs on the latest medical research. Each one gives you the finding, the population it applies to, what it changes in practice, and a link straight to the original source.
Endocrinology & Metabolism
The supporting systematic review favors aldosterone-directed treatment and clearer selection between adrenalectomy and medical therapy for adults with primary aldosteronism.
Rayan Salih · September 1, 2026 · 7 min
Innovation & Devices
Specified ENROUTE neuroprotection system lots were recalled after arterial sheath tip separation reports. Transcarotid teams should quarantine inventory and review potentially affected procedures.
Rayan Salih · 6 min read
Oncology
The accelerated approval covers eligible adults with previously treated multiple myeloma after exposure to both a proteasome inhibitor and an immunomodulatory agent.
Rayan Salih · 6 min read
Infectious Disease
WHO’s 2026 position paper simplifies primary vaccination and concentrates repeat doses on people at greatest risk of severe COVID-19. US clinicians must still follow CDC schedules and FDA-authorized formulations.
Rayan Salih · 6 min read
Oncology
The FDA authorized two zanidatamab-based first-line strategies for unresectable locally advanced or metastatic HER2-positive gastric, gastroesophageal junction, and esophageal adenocarcinoma.
Rayan Salih · 6 min read
Heart and vascular medicine
Trial results, device approvals and practice guidance across cardiology, interventional care and vascular medicine.
Cancer care and research
Practice-changing oncology and hematology research, from early detection through survivorship.
Brain, nerve and cognitive care
Neurology and neuroscience briefs covering diagnosis, disease-modifying therapy and long-term management.
Diabetes, obesity and hormone health
Metabolic medicine: glycemic management, GLP-1 therapeutics, thyroid disease and endocrine practice.
OBGYN and women's medicine
Obstetric, gynecologic and women's health evidence across the reproductive lifespan.
Psychiatry and behavioral medicine
Psychiatry, behavioral health and sleep medicine research with an eye on what changes in clinic.
Infection, immunity and prevention
Infectious disease, immunology and infection prevention, from outbreak response to vaccine evidence.
Regulation, coverage and access
Policy, payment and public health decisions that shape how clinicians practice and patients get care.
Technology at the bedside
Medical devices, diagnostics, digital health and AI tools moving from pipeline into practice.
Reporting from the meetings
Late-breaking data and session highlights from the major medical congresses.
Across the specialties
Concise evidence briefs from across internal medicine, surgery, pediatrics and primary care.
Innovation & Devices
FDA advisers examined whether deramiocel’s cardiac and upper-limb findings outweigh uncertainties in the evidence and risks of repeated cell infusions for Duchenne muscular dystrophy.
Dr. Abu Bakar · 7 min read
Oncology
The FDA granted accelerated approval to vusolimogene oderparepvec plus nivolumab for unresectable advanced melanoma progressing after PD-1 therapy, based on tumor response and response durability.
Dr. Abu Bakar · 6 min read
Infectious Disease
Rapid case growth and very-high national risk in DRC warrant stronger clinical preparedness and cross-border surveillance, while WHO assesses global risk as low and advises against travel or trade restrictions.
Dr. Abu Bakar · 7 min read
Cardiology
The 2026 CKM guideline calls for earlier, integrated prevention when cardiovascular, kidney and metabolic risks coexist, with action spanning primary care, endocrinology, nephrology and cardiology.
Dr. Abu Bakar · 7 min read
Infectious Disease
A multistate outbreak linked to affected alfalfa sprouts requires exposure-specific histories, testing for both pathogens and prompt coordination with public health agencies.
Dr. Abu Bakar · 6 min read
Innovation & Devices
The FDA’s Class I classification covers certain catheter introducers in kits used with Impella heart pumps. Heart teams should verify identifiers and incorporate the manufacturer’s correction into procedural checks.
Rayan Salih · 6 min read
Oncology
In ENDURANCE, indefinite lenalidomide maintenance did not improve 7-year overall survival versus a fixed 2-year course for standard-risk myeloma managed without upfront transplant.
Rayan Salih · 6 min read
Neurology
The cited 2026 WHO media-briefing record does not provide enough verifiable detail to identify revised dementia recommendations. Established guidance still supports integrating cardiovascular and behavioral risk reduction into routine care.
Rayan Salih · 6 min read
One story a day
One health journey each morning — no advice, no alarm, just company for the road.
Endocrinology & Metabolism
The FDA has approved revised labeling for OTC orlistat (alli) warning of rare acute kidney injury, bringing kidney-risk messaging into line across US orlistat products.
Rayan Salih · 6 min read
Infectious Disease
One lot of intravenous tocilizumab-aazg (Tyenne) was recalled nationwide over possible glass particles. Infusion centers, pharmacies and clinics should rapidly quarantine stock and trace prior distribution.
Rayan Salih · 7 min read
Cardiology
TRACK found no cardiovascular benefit and more major bleeding when low-dose rivaroxaban was added in stage 4–5 CKD or dialysis-dependent kidney failure.
Rayan Salih · 6 min read
Women's Health
The FDA approved first-line sacituzumab govitecan plus pembrolizumab for unresectable or metastatic TNBC with PD-L1 CPS ≥10, making validated biomarker testing pivotal to treatment selection.
Rayan Salih · 7 min read
Oncology
Traditional approval makes selpercatinib an established tumor-agnostic option for qualifying RET fusion-positive advanced solid tumors in adults and children age 2 years and older.
Rayan Salih · 7 min read
Oncology
Median overall survival was reported at 13.2 months with daraxonrasib versus 6.6 months with chemotherapy in KRAS-mutant metastatic pancreatic cancer, but comparative uncertainty limits practice implications.
Rayan Salih · 7 min read
Amanda Gray
Contributing writer · PA
A board-certified Physician Assistant who has been practicing medicine since 2008. My clinical experience includes occupational medicine, urgent care, family medicine, and cardiology, with the majority of my career…
Egbavwe Pela
Contributing writer
Dr. Abu Bakar
Contributing writer · PharmD, PhD (Pharmacology)
A Pharm-D and PhD in Pharmacology from Punjab University College of Pharmacy, and I have worked as a registered hospital pharmacist at Jinnah Hospital Lahore. Over the past six years in clinical practice, I have seen…
Rayan Salih
Contributing writer · PharmD, RPh
Rayan is a pharmacist, life science communicator, and health policy researcher with a deep interest in ensuring patient access to innovative and life-changing therapies. She obtained her PharmD at Rosalind Franklin…